AUTH/2070/11/07, AUTH/2072/12/07 & AUTH/2073/12/07: Anonymous v Otsuka and Bristol-Myers Squibb (Abilify) – meeting hospitality allegations (No breach)

📅 2007 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numbersAUTH/2070/11/07; AUTH/2072/12/07; AUTH/2073/12/07
PartiesAnonymous complainants v Otsuka Pharmaceuticals (UK) Ltd and Bristol-Myers Squibb Pharmaceuticals Ltd
ProductAbilify (aripiprazole)
IssueAlleged inappropriate hospitality/meeting arrangements for South Asian Psychiatric Forum meeting
Meeting“Recent Advances in Management of Schizophrenia” (Birmingham)
Scientific content6 hours 30 minutes (1.5 hours Friday evening; 5 hours Saturday)
Attendance69 health professionals attended; plus 5 speakers and a chairperson
Accommodation39 of 69 delegates stayed overnight on Friday
Spouse/partner attendanceOnly spouses who were health professionals and delegates in their own right (five couples)
Hospitality costs (stated)Friday meal/beverages £36.81 per head; overall cost per head £134.20; total cost £9,259.58
EntertainmentNone provided (as stated by companies and accepted by Panel)
Applicable Code year2006
Clauses considered2, 9.1, 19.1
DecisionNo breach
Complaint received28 November 2007 (AUTH/2070/11/07); 3 December 2007 (AUTH/2072/12/07; AUTH/2073/12/07)
Case completed7 January 2008
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • Anonymous complainants alleged Otsuka (and in related complaints, Otsuka and Bristol-Myers Squibb) provided inappropriate hospitality to psychiatrists at a South Asian Psychiatric Forum weekend meeting in Birmingham.
  • Allegations included that some psychiatrists stayed with their wives, that 50 hotel rooms were booked, that it was “not a scientific conference”, and that entertainment was paid for by the company.
  • Complainants also raised concerns about who selected speakers, whether lectures were ABPI-approved, why the event was sponsored, and whether there was a “nexus” between the companies and organisers.
  • The companies submitted a joint response: the meeting was a scientific meeting (“Recent Advances in Management of Schizophrenia”) with 6 hours 30 minutes of scientific content (1.5 hours Friday evening; 5 hours Saturday), no entertainment, and modest hospitality.
  • Sponsorship covered speakers’ honoraria, meeting rooms/equipment, meals/beverages, and overnight accommodation as required; 39 of 69 delegates stayed overnight on Friday.
  • Only spouses who were health professionals and qualified as delegates in their own right attended (five couples). The companies instructed the hotel that uninvited partners were not acceptable and that rooms paid for were single occupancy.
  • The Panel noted the agendas provided by complainants and companies differed; the complainants were anonymous and non-contactable.
⚖️

Outcome

  • No breach of the Code was found.
  • The Panel ruled there had been no breaches of Clauses 2, 9.1 and 19.1.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training